Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA approves TriPath's PREPmate accessory:

This article was originally published in Clinica

Executive Summary

The US FDA has approved for sale TriPath Imaging's accessory product for automating several steps needed to prepare thin-layer slides used with its AutoCyte PREP system for cervical cancer screening. The PREPmate system automatically mixes and removes the specimen from the CytoRich preservative fluid vials and layers the specimen onto the CytoRich density reagent in a test tube for automated slide preparation and staining, says the Burlington, North Carolina firm. With the manual method, the cell suspension is layered onto the slide and stained by a technician.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT071512

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel